To: Jeffrey S. Mitchell who wrote (9302 ) 2/22/2006 9:35:34 AM From: StockDung Read Replies (1) | Respond to of 12465 Plasticon, Ziopharm To Present At Investrend/Arch Investment Conference February 23 / FinancialWire® February 22, 2006 (FinancialWire) Plasticon International (OTC: PLNI) and Ziopharm Oncology (OTCBB: ZIOP) are scheduled to present at the second of the 2006 series of Arch Investment Conferences co-sponsored by Investrend Forums and webcast by Investrend Broadcast. The conference will be held February 23 at the Hotel Plaza Athenee, 37 East 64th Street, New York City. February 22, 2006 (FinancialWire) Plasticon International (OTC: PLNI) and Ziopharm Oncology (OTCBB: ZIOP) are scheduled to present at the second of the 2006 series of Arch Investment Conferences co-sponsored by Investrend Forums and webcast by Investrend Broadcast. The conference will be held February 23 at the Hotel Plaza Athenee, 37 East 64th Street, New York City. Six companies present at each of the Arch Small Cap Investment Conferences (http://www.archconferences.com). If interested in participating, write contact@investrend.com or click on investrend.com . The companies? presentations will be webcast by Investrend Broadcast (http://www.investrendbroadcast.com), and produced by Investrend partner HawkwoodCP. The previous conferences may be accessed via archconferences.com . More information about presenting companies are on their InvestorPower pages at investrend.com . Arch Investment Conferences, Inc. is an investment conference company providing services to small-cap and micro-cap companies from around the world. Arch hosts exclusive events for companies looking to build market support, raise capital, and increase awareness in their stories by meeting with fund managers, analysts, investment bankers, brokers and other members of the investment community. Arch is not only a bridge to the companies of tomorrow, but to the investment ideas of today. Visit archconferences.com for more information. Investrend Forums is at investrendforums.com Plasticon International (www.plasticonintl.com) designs, produces, and distributes high-quality concrete accessories, transportation signage, plastic lumber, and office supplies which are all produced from recycled and recyclable plastics. Plasticon is an innovator of cutting edge design, engineering, and production of industrial and commercial products. Plasticon is a green Company, environmentally friendly, using recycled plastics to produce its line of products. ZIOPHARM Oncology, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of a portfolio of in-licensed cancer drugs to address unmet medical needs. It applies new insights of molecular and cancer biology to the understandings of toxic cancer therapies, and identifies proprietary and related drugs to provide cancer therapy for patients. The company has two product candidates, known as ZIO-101 and ZIO-201, which are in Phase I clinical studies in the United States. It engages in the clinical development of ZIO-101 in patients with advanced myeloma and ZIO-201 in patients with advanced sarcoma. The company intends to market and sell its products in North America. ZIOPHARM Oncology was founded in 2003 and is headquartered in New York City. For up-to-the-minute news, features and links click on financialwire.net . FinancialWire is an independent, proprietary news service of Investrend Information, a division of Investrend Communications, Inc. It is not a press release service and receives no compensation for its news or opinions. Other divisions of Investrend, however, provide shareholder empowerment platforms such as forums, independent research and webcasting. For more information or to receive the FirstAlert daily summary of news, commentary, research reports, webcasts, events and conference calls, click on investrend.com . For a free annual report on a company mentioned in the news, please click on investrend.ar.wilink.com . The FinancialWire NewsFeed is now available in multiple formats to your site or desktop, free. Click on: investrend.com . --------------------------------------------------------------------------------